Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSyros Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q2 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q4 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
Syros Pharmaceuticals, Inc. Earnings Date And Information
Syros Pharmaceuticals, Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $-0.68 earnings per share for the quarter, topping analysts' consensus estimates of $-0.76 by $0.08. The company had revenue of 0 for the quarter and had revenue of 9.94 M for the year. Syros Pharmaceuticals, Inc. has generated $-6 earnings per share over the last year ($-5.81 diluted earnings per share) and currently has a price-to-earnings ratio of -0.03. Syros Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based on prior year's report dates.
Syros Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/31/2024 | Q3 2024 | -$0.76 | -$0.16 | 0.6 | $360,000 | $0 |
| 07/31/2024 | Q2 2024 | -$0.79 | -$0.59 | 0.2 | $460,000 | $0 |
| 05/14/2024 | Q1 2024 | -$0.89 | -$0.10 | 0.79 | N/A | $0 |
| 03/27/2024 | Q4 2023 | -$1.23 | -$2.18 | -0.95 | N/A | $386,000 |
| 11/14/2023 | Q3 2023 | -$1.12 | -$1.43 | -0.31 | $3.94 M | $3.76 M |
| 08/08/2023 | Q2 2023 | -$1.11 | -$1.30 | -0.19 | $3.50 M | $2.83 M |
| 05/10/2023 | Q1 2023 | -$1.12 | -$0.54 | 0.58 | N/A | $2.95 M |
| 03/02/2023 | Q4 2022 | -$1.27 | $0.99 | 2.26 | N/A | $-5,467,000 |
| 11/14/2022 | Q3 2022 | -$3.91 | -$2.24 | 1.67 | $5.18 M | $3.89 M |
| 08/09/2022 | Q2 2022 | -$4.20 | -$5.51 | -1.31 | $4.74 M | $6.28 M |
| 05/16/2022 | Q1 2022 | -$4.80 | -$3.75 | 1.05 | N/A | $5.47 M |
| 03/15/2022 | Q4 2021 | -$4.40 | -$3.78 | 0.62 | N/A | $7.80 M |
| 11/05/2021 | Q3 2021 | -$4.30 | -$4.14 | 0.16 | $4.49 M | $5.70 M |
| 08/05/2021 | Q2 2021 | -$3.60 | -$3.60 | 0 | $4.13 M | $5.16 M |
| 05/06/2021 | Q1 2021 | -$5.50 | -$2.32 | 3.18 | N/A | $4.83 M |
| 03/04/2021 | Q4 2020 | -$5.40 | -$4.91 | 0.49 | N/A | $5.70 M |
| 11/05/2020 | Q3 2020 | -$3.80 | -$4.26 | -0.46 | $2.54 M | $3.83 M |
| 08/06/2020 | Q2 2020 | -$4.00 | -$3.76 | 0.24 | $1.90 M | $3.19 M |
| 05/07/2020 | Q1 2020 | -$4.50 | -$3.92 | 0.58 | N/A | $2.38 M |
| 03/05/2020 | Q4 2019 | -$4.70 | -$4.60 | 0.1 | N/A | $508,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Syros Pharmaceuticals, Inc. Earnings: FAQ's
Syros Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based offlast year's report dates.
In the previous quarter, Syros Pharmaceuticals, Inc. (:SYRS) reported $-0.68 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.76 by $0.08.
The conference call for Syros Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Syros Pharmaceuticals, Inc.'s latest earnings report can be read online.
Syros Pharmaceuticals, Inc. (:SYRS) has a recorded annual revenue of $9.94 M.
Syros Pharmaceuticals, Inc. (:SYRS) has a recorded net income of $-164,574,000.Syros Pharmaceuticals, Inc. has generated $-5.81 earnings per share over the last four quarters.
Syros Pharmaceuticals, Inc. (:SYRS) has a price-to-earnings ratio of -0.03 and price/earnings-to-growth ratio is -0.